ENO2 and neoplasm: NSE and CgA expression correlate with the differentiation level of the tumor, metastatic sites and response to treatment; patients in stage I and stage II have low levels of CgA and favorable outcome, while patients with advanced disease stages (III and IV) have high levels of NSE and CgA and bad prognosis [39, 40].